Reversing the negative effect of adenosine A1 receptor-targeted immunometabolism modulation on melanoma by a co-delivery nanomedicine for self-activation of anti-PD-L1 DNAzyme
暂无分享,去创建一个
Peng Liu | Jinsong Ding | Benliang Wei | Wenhu Zhou | Juan Su | Guanxiong Zhang | Ying-Ying Peng | Xiang Chen | Hong Liu | Hailun Zhang | J. Su | Jianyi Guo
[1] L. Teng,et al. Smart drug delivery systems for precise cancer therapy , 2022, Acta pharmaceutica Sinica. B.
[2] Yan Yang,et al. Targeting the Negative Feedback of Adenosine‐A2AR Metabolic Pathway by a Tailored Nanoinhibitor for Photothermal Immunotherapy , 2022, Advanced science.
[3] L. Zitvogel,et al. Immunogenic cell stress and death , 2022, Nature Immunology.
[4] Dunwan Zhu,et al. Programmed polymersomes with spatio-temporal delivery of antigen and dual-adjuvants for efficient dendritic cells-based cancer immunotherapy , 2022, Chinese Chemical Letters.
[5] Xiaojing Liu,et al. Dynamic Adjust of Non‐Radiative and Radiative Attenuation of AIE Molecules Reinforces NIR‐II Imaging Mediated Photothermal Therapy and Immunotherapy , 2022, Advanced science.
[6] Yuanyuan Yang,et al. Glutamine Antagonist Synergizes with Electrodynamic Therapy to Induce Tumor Regression and Systemic Antitumor Immunity. , 2022, ACS nano.
[7] Dunwan Zhu,et al. Symphony of nanomaterials and immunotherapy based on the cancer–immunity cycle , 2021, Acta pharmaceutica Sinica. B.
[8] Fuan Wang,et al. Boosting Cancer Immunotherapy via the Convenient A2AR Inhibition Using a Tunable Nanocatalyst with Light‐Enhanced Activity , 2021, Advanced materials.
[9] Jinsong Ding,et al. Anti‐PD‐L1 DNAzyme Loaded Photothermal Mn2+/Fe3+ Hybrid Metal‐Phenolic Networks for Cyclically Amplified Tumor Ferroptosis‐Immunotherapy , 2021, Advanced healthcare materials.
[10] Zhigang Xu,et al. Applying nanotechnology to boost cancer immunotherapy by promoting immunogenic cell death , 2021, Chinese Chemical Letters.
[11] Jie Tan,et al. Metal-phenolic networks modified polyurethane as periosteum for bone regeneration , 2021, Chinese Chemical Letters.
[12] Ying Cai,et al. T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy , 2021, Nature Nanotechnology.
[13] Zhijun Sun,et al. Calcium Phosphate‐Reinforced Metal‐Organic Frameworks Regulate Adenosine‐Mediated Immunosuppression , 2021, Advanced materials.
[14] N. Chandel,et al. Cancer metabolism: looking forward , 2021, Nature Reviews Cancer.
[15] F. Di Virgilio,et al. ATP and cancer immunosurveillance , 2021, The EMBO journal.
[16] Ming-zhu Jin,et al. Immunogenic Cell Death-Based Cancer Vaccines , 2021, Frontiers in Immunology.
[17] A. Rustgi,et al. Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment. , 2021, Trends in cancer.
[18] Sixian Liang,et al. ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling. , 2021, Life sciences.
[19] Peng Liu,et al. Metal-phenolic networks for cancer theranostics. , 2021, Biomaterials science.
[20] Jinsong Ding,et al. A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances , 2021, Journal of Nanobiotechnology.
[21] J. Ji,et al. Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles , 2021, Nature Communications.
[22] T. Tsuzuki,et al. Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival , 2021, Cancer Immunology, Immunotherapy.
[23] Xuesi Chen,et al. In situ vaccination and gene-mediated PD-L1 blockade for enhanced tumor immunotherapy , 2021 .
[24] Youqing Shen,et al. Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy. , 2020, Biomaterials.
[25] Meiwan Chen,et al. Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition , 2020 .
[26] Q. Wei,et al. ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway , 2020, OncoTargets and therapy.
[27] Peng Liu,et al. Core-Shell Nanosystems for Self-Activated Drug-Gene Combinations against Triple-Negative Breast Cancer. , 2020, ACS applied materials & interfaces.
[28] Xiang Chen,et al. Plasma adenosine is linked to disease activity and response to treatment in patients with chronic spontaneous urticaria , 2020, Allergy.
[29] L. Buisseret,et al. The adenosine pathway in immuno-oncology , 2020, Nature Reviews Clinical Oncology.
[30] Peng Liu,et al. Co-delivery of Doxorubicin and DNAzyme Using ZnO@polydopamine Core-Shell Nanocomposites for Chemo/Gene/Photothermal Therapy. , 2020, Acta biomaterialia.
[31] M. Hung,et al. ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis. , 2020, Cancer cell.
[32] G. Yegutkin,et al. Adenosine Metabolism: Emerging Concepts for Cancer Therapy. , 2019, Cancer cell.
[33] Peng Liu,et al. Oxygen-self-supplying and HIF-1α inhibiting core-shell nano-system for hypoxia-resistant photodynamic therapy. , 2019, ACS applied materials & interfaces.
[34] Wenbin Lin,et al. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy. , 2018, Angewandte Chemie.
[35] Li Liu,et al. ATP-Driven Temporal Control over Structure Switching of Polymeric Micelles. , 2018, Biomacromolecules.
[36] F. Di Virgilio,et al. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment , 2018, Nature Reviews Cancer.
[37] L. Emens,et al. Targeting adenosine for cancer immunotherapy , 2018, Journal of Immunotherapy for Cancer.
[38] J. Steyaert,et al. How the Warburg effect supports aggressiveness and drug resistance of cancer cells? , 2018, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[39] G. Beldi,et al. Mechanisms of ATP Release by Inflammatory Cells , 2018, International journal of molecular sciences.
[40] Yun Huang,et al. Elevated Adenosine Induces Placental DNA Hypomethylation Independent of A2B Receptor Signaling in Preeclampsia , 2017, Hypertension.
[41] Juewen Liu,et al. Metal Sensing by DNA. , 2017, Chemical reviews.
[42] S. Loi,et al. Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy , 2017, The Journal of clinical investigation.
[43] Juewen Liu,et al. Theranostic DNAzymes , 2017, Theranostics.
[44] Rong-Fu Wang,et al. The distribution and function of human memory T cell subsets in lung cancer , 2017, Immunologic Research.
[45] Pornpimol Charoentong,et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.
[46] F. Di Virgilio,et al. Extracellular purines, purinergic receptors and tumor growth , 2016, Oncogene.
[47] A. Subudhi,et al. Beneficial Role of Erythrocyte Adenosine A2B Receptor–Mediated AMP-Activated Protein Kinase Activation in High-Altitude Hypoxia , 2016, Circulation.
[48] X. Long,et al. Differential Expression of Adenosine P1 Receptor ADORA1 and ADORA2A Associated with Glioma Development and Tumor-Associated Epilepsy , 2016, Neurochemical Research.
[49] Hong Liu,et al. Beneficial and detrimental role of adenosine signaling in diseases and therapy. , 2015, Journal of applied physiology.
[50] K. Uzawa,et al. Adenosine A2b receptor promotes progression of human oral cancer , 2015, BMC Cancer.
[51] A. Ribas,et al. Anti-programmed cell death protein-1/ligand-1 therapy in different cancers , 2015, British Journal of Cancer.
[52] W. Cao,et al. Omega-3 PUFAs induce apoptosis of gastric cancer cells via ADORA1. , 2014, Frontiers in bioscience.
[53] Jeffrey A. Wiser,et al. ImmPort: disseminating data to the public for the future of immunology , 2014, Immunologic Research.
[54] E. Condom,et al. High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors , 2014, Mediators of inflammation.
[55] L. Antonioli,et al. Immunity, inflammation and cancer: a leading role for adenosine , 2013, Nature Reviews Cancer.
[56] L. Belardinelli,et al. Alterations in Adenosine Metabolism and Signaling in Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis , 2010, PloS one.
[57] G. Mutlu,et al. Adenosine A1 receptor, a target and regulator of ERα action, mediates the proliferative effects of estradiol in breast cancer , 2009, Oncogene.
[58] M. Bours,et al. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. , 2006, Pharmacology & therapeutics.
[59] S. Baltacı,et al. Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality. , 2003, European urology.
[60] H. Gabbert,et al. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.